权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Follicular morphogenesis during perinatal development

围产期发育过程中的卵泡形态发生

基本信息

批准号：
8091316
负责人：
SHYAMAL K. ROY
金额：
$ 25.26万
依托单位：
UNIVERSITY OF NEBRASKA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-07-01 至 2012-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8091316
关键词：
Address Affect Antibodies Attenuated Cells Communication Complement Factor B Complementary DNA Contraceptive methods Cues Defect Development Developmental Process ESR1 gene ESR2 gene Endocrine Estradiol Estrogen Receptors Event Exposure to Fertility Fertilization Fetal Development Funding G-Protein-Coupled Receptors Goals Growth Differentiation Factor 9 Hamsters Human In Vitro Infertility Knowledge Laboratories Lead Life Modeling Molecular Morphogenesis Mutation Neonatal Oocytes Outcome Ovarian Ovary Ovulation Perinatal Perinatal Exposure Physiological Play Premature Ovarian Failure Primordial Follicle Proteins Protocols documentation RNA Interference Regulation Research Role Signal Transduction Small Interfering RNA Somatic Cell Sterility System Testing Therapeutic Transforming Growth Factors Transgenes Woman base bone morphogenetic protein receptor type II egg fetal folliculogenesis granulosa cell improved in vivo insight intraovarian novel therapeutics paracrine postnatal prenatal receptor receptor expression reproductive tool

项目摘要

DESCRIPTION (provided by applicant): Formation and development of primordial follicles are obligatory events for successful folliculogenesis and fertility. Defects in these steps lead to ovarian dysgenesis or premature ovarian failure and ultimately infertility. Our long-term goal is to elucidate the regulatory mechanisms controlling the formation and development of the primordial follicles as a necessary prerequisite to the development of improved therapeutic management of human infertility and contraception. Although evidence suggests that growth differentiation factor 9 (GDF9) or E2 stimulates preantral follicle development, virtually nothing is known about their role in primordial folliculogenesis or the mechanisms therein. This renewal application is focused on filling this knowledge gap. During the last funded period, we have shown that inactivation of FSH during fetal development disrupts primordial folliculogenesis, which correlates with low expression of GDF9 and estrogen receptors (ESR). Further, FSH treatment upregulates GDF9 and ESR expression. Our preliminary results indicate that (1) suppression of endogenous GDF9 expression in vitro retards primordial folliculogenesis, (2) E2 stimulates primordial follicle formation in vitro, (3) fetal exposure to an FSHantiserum blocks the expression of the GDF9 receptors, such as bone morphogenetic protein receptor II [BMPRII] and transforming growth factor B receptor type I [TBRI], and blocks the expression of ESR1 and ESR2, and (4) siRNA knockdown of a G-protein coupled receptor 30 (GPR30), a transmembrane ESR in vitro attenuates the formation of primordial follicles. Based on these observations we hypothesize that GDF9 and E2 promote the differentiation of somatic cells into granulosa cells leading to the formation of primordial follicles by mechanisms that involve a concerted action of the GDF9 receptors (BMPRII and TBRI), and the ESR (ESR1, ESR2 and GPR30). We further postulate that FSH regulates the action of GDF9 and E2 by modulating the expression of their receptors. The hypothesis will be tested with the following specific aims: 1. To reveal the physiological importance of GDF9 expression in the differentiation of somatic cells into pregranulosa cells leading to primordial follicle formation. We will determine the need for intraovarian GDF9, and its mechanisms of action. 2. To examine the physiological importance of the ESR in the differentiation of somatic cells into pregranulosa cells leading to primordial follicle formation. We will determine the need for the classic ESR and GPR30 with respect to GDF9 action. We will use fetal and neonatal hamster ovaries in vivo and in vitro (primordial follicles do not appear until 8th day of life), RNAi, antisense oligodeoxynucleotides, pharmacological, morphological and molecular approaches to address the specific aims. The successful completion of this project should advance our understanding of the mechanisms involved in the morphogenesis of primordial follicles. Lay summary: The primordial follicle stock represents a nonrenewable follicular reserve for the entire reproductive life of the mammalian species, including the human, and determines the fertility and fecundity of the species. The purpose of the proposed research is to elucidate the regulatory mechanisms controlling the formation and development of the primordial follicles. The outcomes will have a significant impact on the development of improved or novel therapeutic management of human infertility and contraception.

描述（由申请人提供）：原始卵泡的形成和发育是成功卵泡形成和生育的必要事件。这些步骤的缺陷导致卵巢发育不良或卵巢早衰，最终导致不孕。我们的长期目标是阐明控制原始卵泡形成和发育的调控机制，作为改进人类不孕症和避孕治疗管理的必要前提。虽然有证据表明生长分化因子9 （GDF9）或E2刺激腔前卵泡发育，但实际上对它们在原始卵泡发生中的作用及其机制一无所知。这个更新应用程序的重点是填补这一知识空白。在上一个资助期内，我们已经证明胎儿发育期间FSH失活会破坏原始卵泡发生，这与GDF9和雌激素受体（ESR）的低表达相关。此外，FSH处理上调GDF9和ESR的表达。我们的初步结果表明：(1)体外抑制内源性GDF9的表达会延缓原始卵泡的形成，(2)E2刺激体外原始卵泡的形成，(3)胎儿暴露于fshan抗血清中会阻断GDF9受体的表达，如骨形态发生蛋白受体II （BMPRII）和转化生长因子B受体I型（TBRI），并阻断ESR1和ESR2的表达，以及(4)g蛋白偶联受体30 （GPR30）的siRNA敲低。体外跨膜ESR可减弱原始卵泡的形成。基于这些观察结果，我们假设GDF9和E2通过GDF9受体（BMPRII和TBRI）和ESR （ESR1， ESR2和GPR30）协同作用的机制促进体细胞向颗粒细胞的分化，从而导致原始卵泡的形成。我们进一步假设FSH通过调节GDF9和E2受体的表达来调节它们的作用。该假设将通过以下具体目的进行检验：1。揭示GDF9在体细胞向颗粒前细胞分化并导致原始卵泡形成过程中的生理意义。我们将确定卵巢内GDF9的需求及其作用机制。2. 探讨ESR在体细胞向颗粒前细胞分化并导致原始卵泡形成过程中的生理意义。我们将确定在GDF9行动方面是否需要经典的ESR和GPR30。我们将在体内和体外使用胎儿和新生的仓鼠卵巢（原始卵泡直到生命的第8天才出现），RNAi，反义寡脱氧核苷酸，药理学，形态学和分子方法来解决特定的目标。该项目的成功完成将促进我们对原始卵泡形态发生机制的理解。摘要：原始卵泡群代表了包括人类在内的哺乳动物整个生殖生命中不可再生的卵泡储备，并决定了物种的生育能力和繁殖力。本研究的目的是阐明控制原始卵泡形成和发育的调控机制。该结果将对人类不孕症和避孕的改进或新的治疗管理的发展产生重大影响。